9epu
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of the human CDKL5 kinase domain with compound CAF-382== | |
- | + | <StructureSection load='9epu' size='340' side='right'caption='[[9epu]], [[Resolution|resolution]] 2.60Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[9epu]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9EPU OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9EPU FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.6Å</td></tr> | |
- | [[Category: | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1H6P:~{N}-[5-[(5-propan-2-yl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide'>A1H6P</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9epu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9epu OCA], [https://pdbe.org/9epu PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9epu RCSB], [https://www.ebi.ac.uk/pdbsum/9epu PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9epu ProSAT]</span></td></tr> |
- | [[Category: | + | </table> |
- | [[Category: | + | == Disease == |
- | [[Category: | + | [https://www.uniprot.org/uniprot/CDKL5_HUMAN CDKL5_HUMAN] Note=Chromosomal aberrations involving CDKL5 are found in patients manifesting early-onset seizures and spams and psychomotor impairment. Translocation t(X;6)(p22.3;q14); translocation t(X;7)(p22.3;p15). Epileptic encephalopathy, early infantile, 2 (EIEE2) [MIM:[https://omim.org/entry/300672 300672]: A severe form of epilepsy characterized by seizures or spasms beginning in infancy. Patients with epileptic encephalopathy early infantile type 2 manifest features resembling Rett syndrome such as microcephaly, lack of speech development, stereotypic hand movements. Note=The disease is caused by mutations affecting the gene represented in this entry.<ref>PMID:15917271</ref> <ref>PMID:16935860</ref> <ref>PMID:12736870</ref> <ref>PMID:15492925</ref> <ref>PMID:15499549</ref> <ref>PMID:15689447</ref> <ref>PMID:16015284</ref> <ref>PMID:16611748</ref> <ref>PMID:18790821</ref> <ref>PMID:17993579</ref> <ref>PMID:18809835</ref> <ref>PMID:19253388</ref> <ref>PMID:19241098</ref> |
- | [[Category: Lakshminarayana | + | == Function == |
- | [[Category: | + | [https://www.uniprot.org/uniprot/CDKL5_HUMAN CDKL5_HUMAN] Mediates phosphorylation of MECP2.<ref>PMID:15917271</ref> <ref>PMID:16935860</ref> |
- | [[Category: | + | == References == |
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Bakshi S]] | ||
+ | [[Category: Brooke L]] | ||
+ | [[Category: Bullock AN]] | ||
+ | [[Category: Chen X]] | ||
+ | [[Category: Lakshminarayana B]] | ||
+ | [[Category: Newman JA]] | ||
+ | [[Category: Richardson W]] |
Current revision
Crystal structure of the human CDKL5 kinase domain with compound CAF-382
|